Treatment of junctional epidermolysis bullosa with epidermal autografts.
We have successfully treated chronic facial erosions in three boys with junctional epidermolysis bullosa. In each patient, keratinocytes were harvested from the roof of suction blisters created on clinically uninvolved skin. They were grown in tissue culture on collagen sponges and grafted onto facial erosions that were previously treated with 2% mupirocin ointment. This experimental antibiotic ointment has proved efficacy in eradicating cutaneous pathogens such as Staphylococcus aureus from chronic wounds. In two patients, complete reepithelialization was achieved over 7 and 10 months, respectively, and partial reepithelialization occurred in another patient in whom treatment is ongoing. Epidermal autografts are a promising means for improving function and appearance in eroded skin caused by junctional epidermolysis bullosa.
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D046508:Culture Techniques / Q000379:methods; D004820:Epidermolysis Bullosa / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D005227:Fatty Acids / Q000627:therapeutic use; D006085:Graft Survival; D006801:Humans; D008297:Male; D016712:Mupirocin; D012867:Skin / Q000473:pathology; D016038:Skin Transplantation; D014182:Transplantation, Autologous / Q000379:methods*
D000900:Anti-Bacterial Agents; D005227:Fatty Acids; D016712:Mupirocin